Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
385
-
Total 13F shares, excl. options
-
368M
-
Shares change
-
-2.16M
-
Total reported value, excl. options
-
$10.8B
-
Value change
-
-$50.8M
-
Put/Call ratio
-
0.98
-
Number of buys
-
194
-
Number of sells
-
-160
-
Price
-
$29.45
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q4 2019
460 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q4 2019.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 385 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 368M shares
of 493M outstanding shares and own 74.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (34.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (33.4M shares), WELLINGTON MANAGEMENT GROUP LLP (30.9M shares), PRIMECAP MANAGEMENT CO/CA/ (30.6M shares), BlackRock Inc. (19.5M shares), AMUNDI PIONEER ASSET MANAGEMENT INC (16.3M shares), Invesco Ltd. (14.2M shares), LAZARD ASSET MANAGEMENT LLC (14.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10.6M shares), and STATE STREET CORP (10.2M shares).
This table shows the top 385 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.